J. Peter Paredes

  • Teva v. Sandoz: The New Standard of Review In Claim Construction

    In Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc., the Supreme Court addressed the question of what the standard of review should be for patent claim construction. In its decision on January 20, 2015, the Court held that a federal appellate court could only overturn a district court’s factual findings if those findings were determined to be clearly erroneous.

    J. Peter Paredes/ Rosenbaum IP- 22 readers -